Articles by tag: autoimmune-diseases

Universal CAR-T therapy: FDA allows trials for autoimmune diseases

FDA approved clinical trials of allogeneic CAR-T cell therapy QT-019C for lupus and scleroderma. Savings up to $100 billion, no chemotherapy. Learn about the breakthrough.

CAR-T therapy for lupus: FDA approval 2026

Analysis of FDA approval of the first CAR-T cell therapy for severe lupus. Key players, forecasts, and hidden risks. Find out who is leading the race.